Social media

From imaging to cardiovascular care, AI-enabled devices are everywhere. But how do you navigate FDA regulations when there’s no unique pathway? Explore key insights on 510(k), De Novo, and lifecycle management in our new...

World Diabetes Day takes place on 14 November 2025. As the incidence of obesity and diabetes have grown in tandem to epidemic proportions, there is growing demand for treatments intended for patients with both conditions...

World Diabetes Day takes place on 14 November. Read the article to find out how multi-indication drug development has gained traction due to a better understanding of glucose metabolism and its critical link to various d...

Did you know? JCA findings aren’t binding—but they do shape national HTA decisions. Learn how to tailor your strategy for each EU market while staying aligned with JCA requirements. Download the whitepaper: https://ow.ly...

Did you know? JCA findings aren’t binding—but they do shape national HTA decisions. Learn how to tailor your strategy for each EU market while staying aligned with JCA requirements. Download the whitepaper: https://ow.ly...

Digital health technologies don’t just modernize clinical trials; they deliver measurable business value. From reducing trial timelines to improving patient retention and cutting costs, DHTs are proving their ROI across...

For sponsors committed to leveraging digital measures in their protocol designs: How do you select the right digital measure? For those searching for a solution. ICON’s proprietary Atlas Network supports sponsors in sel...

Meet the ICON Biotech team at #ASH25, booth \#2161 to discover how our collaborative, agile, and science-driven team partners with biotech sponsors to navigate complexity and accelerate oncology clinical development—from...

ICON has done it again! For the third consecutive year, we’ve been named one of TIME and Statista’s World’s Best Companies of 2025. This honour celebrates our people, our purpose, and our progress. Thank you to everyone ...

We’re proud to share that ICON has been named one of TIME and Statista’s World’s Best Companies of 2025 — for the third year in a row! This recognition reflects our continued commitment to innovation, growth, employee s...

Missed our recent webinar on advancing clinical trials in neurodegenerative diseases? If you were unable to attend Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases, the fu...

Smarter monitoring drives better trial delivery. ICON’s whitepaper explores how evolving Clinical Research Associate roles are improving efficiency, oversight and site engagement. Read more: https://www.iconplc.com/in...